Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
Renée Maria Saliby, Chris Labaki, Tejas Jammihal, Wanling Xie, Maxine Sun, Valisha Shah, Eddy Saad, M. Harry Kane, Soki Kashima, Katherine Sadak, Talal El Zarif, Deepak Poduval, Robert J. Motzer, Thomas Powles, Brian I. Rini, Laurence Albigès, Sumanta K. Pal, Bradley A. McGregor, Rana R. McKay, Sabina Signoretti, Eliezer M. Van Allen, Sachet A. Shukla, Toni K. Choueiri, David A. Braun
Topics & Concepts
Renal cell carcinomaJavelinImmunotherapyTargeted therapyKidney cancerCancer researchTranscriptomeMedicineNivolumabCarcinomaImmune checkpointOncologyImmune systemInternal medicineImmunologyBiologyCancerGeneGene expressionGeneticsThrowingMechanical engineeringEngineeringRenal cell carcinoma treatmentCancer Genomics and DiagnosticsRenal and related cancers